Quick Answer
Hepion Pharmaceuticals, Inc. reported Net Income of -$8.28 million for fiscal year 2025.
Hepion Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$8.28M | +37.3% |
| 2024 | -$13.19M | +73.0% |
| 2023 | -$48.93M | -15.9% |
| 2022 | -$42.20M | -29.0% |
| 2021 | -$32.72M | -60.8% |
| 2020 | -$20.35M | -189.2% |
| 2019 | -$7.04M | +25.5% |
| 2018 | -$9.45M | +36.5% |
| 2017 | -$14.89M | +12.4% |
| 2016 | -$17.00M | -18.5% |
| 2015 | -$14.35M | -171.7% |
| 2014 | -$5.28M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$472.5K | +90.3% | +54.7% |
| June 30, 2025 | -$1.04M | +73.4% | +82.9% |
| March 31, 2025 | -$6.11M | -114.0% | -25.5% |
| September 30, 2024 | -$4.87M | +53.8% | -24.0% |
| June 30, 2024 | -$3.93M | +72.1% | -37.5% |
| March 31, 2024 | -$2.85M | +78.5% | +72.9% |
| September 30, 2023 | -$10.53M | -23.2% | +25.2% |
| June 30, 2023 | -$14.08M | +29.3% | -6.2% |
- Hepion Pharmaceuticals, Inc. showed an increase of +37.3% in Net Income compared to the prior fiscal year.
- Over the 2014–2025 period, Hepion Pharmaceuticals, Inc.’s net income has declined by 56.8% (from -$5.28 million to -$8.28 million).
- The most recent figure is from Hepion Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: